Thus, inhibition of either MEK1/2 or its upstream activator Raf completely prevents SAH-induced ERK1/2 activation and vasoconstrictor receptor upregulation in cerebral arteries and alleviates delayed cerebral ischemia [17,18,26]. Here, MAP2K1 is linked to brain ischemia.